Prognostic value of the quantitative measurement of the oncoprotein p185Her-2/neuin a group of patients with breast cancer and positive node involvement-Reference-Cited by-同舟云学术

Prognostic value of the quantitative measurement of the oncoprotein p185Her-2/neuin a group of patients with breast cancer and positive node involvement

Published:2002-08-27 Issue:6 Volume:101 Page:539-544
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bohn Uriel,Aguiar José,Bilbao Cristina,Murias Adolfo,Vega Victor,Chirino Ricardo,Díaz-Chico Nicolas,Díaz-Chico Juan C.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference46 articles.

1. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors;Rilke;Int J Cancer,1991

2. Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1,103 breast cancer;Ciocca;J Nat Cancer Inst,1992

3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

4. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer;Slamon;Science,1989

5. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease;Press;Cancer Res,1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of HER-2 and Hormone Receptors and P53 Mutations in the Pathologic Specimens of Breast Cancer Patients;International Journal of Breast Cancer;2014

2. Cathepsin D as an indicator of clinical outcome in early breast carcinoma during the first 3 years of follow-up;Biomarkers in Medicine;2013-10

3. Houttuyninum, an active constituent of Chinese herbal medicine, inhibits phosphorylation of HER2/neu receptor tyrosine kinase and the tumor growth of HER2/neu-overexpressing cancer cells;Life Sciences;2012-05

4. Expression and prognostic significance of the EGFR in solid tumors;EGFR Signaling Networks in Cancer Therapy;2008

5. SUCI02 inhibits the erbB-2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G1 phase in breast cancer cells;Cancer Science;2006-01